Fundraising FoxForesite Capital — 2021 Investments
15 investments dated 2021 · listed companies and verified rows first · show all
Invivyd is a biopharmaceutical company that develops antibody-based product candidates for the prevention and treatment of serious viral infectious diseases, combining viral surveillance and predictive modeling with antibody engineering.
BiotechHealthtechWaltham, US
Tillman U. Gerngross(Executive Officer, Director)Marc Elia(Founder)inLynn Connolly(Executive Officer)inEric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)inRebecca Dabora(Executive Officer)in
Co-investorsBain Capital Life SciencesGV (Google Ventures)MRL Ventures FundPremji InvestRA CapitalFidelity Investments+6 more
Silence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.
BiotechLondon
Craig Tooman(Executive Officer)inGiles Campion(Executive Officer)Mark Rothera(Executive Officer, Director)inBarbara Ruskin(Executive Officer)
BoardJames Ede-Golightly(Director)Alistair Gray(Director)
Co-investorsMC Healthcare VenturesNextech InvestVivo Capital
Pardes Biosciences develops oral medications designed to treat and prevent viral infections, including COVID-19.
BiotechHealthtechSan Francisco, US
Uri Lopatin(CEO)inUri A. Loptain(Executive Officer, Director)Heidi Henson(Executive Officer)inElizabeth Lacy(Executive Officer)Lee Arnold(Executive Officer)
BoardJ. Jay Lobell(Director)
Board seatJames B. Tananbaum· per SEC Form D
Co-investorsFrazier Life SciencesY CombinatorKhosla Ventures
Affinivax was a clinical-stage biopharmaceutical company that developed next-generation pneumococcal vaccines using its proprietary Multiple Antigen Presenting System (MAPS) platform technology.
BiotechMedical DevicesCambridge, US
Richard Malley(Director)inKamran Tavangar(Executive Officer)Steven Brugger(Executive Officer, Director)in
BoardRobert More(Director)Frances Heller(Director)George Siber(Director)
Co-investorsBain Capital Life SciencesEcoR1 CapitalViking GlobalBain CapitalRock Springs CapitalT. Rowe Price
Element Biosciences develops biological analysis platforms and DNA sequencing tools for scientists and research institutions.
BiotechDeep TechHardwareMedical Devices
Matthew Kellinger(Founder)Michael Previte(Founder)Molly He(Founder)
Co-investorsDraper AssociatesFusionRA CapitalTSVCVenrockWellington Management
BGI (Huada) is a genomics research and services organization offering clinical genetic testing, scientific research services, forensic/judicial testing, and sequencing instruments.
BiotechDeep TechDigital Health
Wang Jian(Founder)
Co-investorsF-Prime CapitalGreen Pine Capital Partners
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Roger Jeffs(Co-Founder and Vice Chairman)inFraser Wright(Scientific Co-Founder and Chief Gene Therapy Officer)inShankar Ramaswamy(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)Britt Petty(Chief Manufacturing Officer)in
Co-investorsPatient Square CapitalPremji InvestAlumni VenturesAmplo VenturesAnjostBluebird Ventures+3 more
Seranova is a biotech company that combines REAP autoantibody profiling with clinically linked patient cohorts to identify naturally occurring protective autoantibodies against specific extracellular targets and translate those protective associations into therapeutic hypotheses.
AI & Machine LearningBiotechDeep TechNew Haven, US
Aaron Ring(Manager)inBeatrice McQueen(Executive Officer)
BoardJim Tananbaum(Manager)
Co-investorsARCH Venture PartnersAxial VC
Theseus builds robotic situational awareness software using visual positioning for drones that operate in GPS-denied environments.
Advanced ManufacturingAI & Machine LearningDefense TechHardwareRoboticsSan Francisco, US
Ian Laffey(Founder)inSacha Lévy(Founder)inCarl Schoeller(Founder)Yasmin Acevedo(Recruiter)Luca Lery Moffat(COO)
Co-investorsY CombinatorFirst Round CapitalPioneerAntlerEndor CapitalFusion+7 more
Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.
BiotechCambridge, US
Andrew Ashe(Executive Officer)Sekar Kathiresan(Founder)inAndrew Bellinger(Executive Officer)Kiran Musunuru(Founder)
BoardJohn Evans(Director)Anthony Philippakis(Director)in
Co-investorsARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalvenBio PartnersWellington Management+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Fl2021-001Interline Therapeutics, Inc.Interline TherapeuticsTesseract HealthXinthera
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.